Stocks and Investing
Stocks and Investing
Tue, January 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Pete Stavropoulos Initiated (VERA) at Buy on, Jan 8th, 2024
Pete Stavropoulos of Cantor Fitzgerald, Initiated "Vera Therapeutics, Inc." (VERA) at Buy on, Jan 8th, 2024.
Pete has made no other calls on VERA in the last 4 months.
There are 4 other peers that have a rating on VERA. Out of the 4 peers that are also analyzing VERA, 0 agree with Pete's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Pete
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Wednesday, December 27th, 2023
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $29 on, Monday, December 18th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Thursday, November 30th, 2023
- Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023
Contributing Sources